Vasopressin

Vasopressin is a synthetic peptide hormone used primarily to increase blood pressure in adults with vasodilatory shock and to manage symptoms of central diabetes insipidus. It acts as a potent vasoconstrictor and antidiuretic agent.

Dosage for vasopressin is highly individualized and depends entirely on the condition being treated. Because of its potency, it is measured in 'Units' rather than milligrams.

• Vasodilatory Shock: For patients in shock, the standard starting dose is typically 0.01 to 0.03 units per minute via continuous intravenous infusion. Healthcare providers may titrate the dose upward to a maximum of 0.07 units per minute if the target blood pressure is not reached. Higher doses are generally avoided due to the increased risk of severe side effects like intestinal or cardiac ischemia (lack of blood flow).
• Central Diabetes Insipidus: The dosage for diabetes insipidus can be administered intramuscularly or subcutaneously. The typical dose is 5 to 10 units, administered two to three times daily as needed to control thirst and urination. The dose is adjusted based on the patient's urinary output and urine specific gravity (a measure of urine concentration).
• Abdominal Distension: An initial dose of 5 units may be given, followed by 10 units every 3 to 4 hours if necessary.

Vasopressin is used in pediatric populations, but with extreme caution. Dosing is often based on the child's weight or body surface area.

• Diabetes Insipidus: Pediatric doses are significantly lower than adult doses and must be carefully calculated by a pediatric endocrinologist. Typical ranges may start as low as 2.5 units once or twice daily.
• Shock (Off-label): In pediatric intensive care, vasopressin may be used at doses starting at 0.0003 units/kg/minute and titrated carefully.

Renal Impairment

Patients with chronic kidney disease may require more frequent monitoring of electrolytes and fluid balance. While the drug is partially cleared by the kidneys, the primary concern is the potential for the drug to cause further renal strain through vasoconstriction of the renal arteries.

Hepatic Impairment

Since the liver is a primary site of vasopressin metabolism, patients with severe liver failure may experience a prolonged effect of the drug. Close monitoring of blood pressure and signs of water intoxication is necessary.

Elderly Patients

Older adults are more susceptible to the side effects of vasopressin, particularly the risk of hyponatremia (low blood sodium) and cardiac complications. Healthcare providers typically start at the lower end of the dosing range and monitor heart function closely.

Vasopressin is not a medication you take at home in a pill form. It is an injectable medication. If you are receiving this for diabetes insipidus, a nurse or doctor will teach you or your caregiver how to perform subcutaneous or intramuscular injections.

• Preparation: Always check the solution for particles or discoloration before use.
• Site Rotation: If injecting at home, rotate the injection sites (thigh, abdomen, or upper arm) to prevent skin irritation or fat buildup.
• Storage: Most formulations of vasopressin should be stored in the refrigerator (2°C to 8°C), although some brands allow for room temperature storage for limited periods. Always check the specific manufacturer's label.

If you are using vasopressin for diabetes insipidus and miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and return to your regular schedule. Do not 'double up' on doses, as this can lead to water intoxication.

An overdose of vasopressin leads to water intoxication, which is a life-threatening condition where the body's sodium levels become dangerously low due to excessive water retention.

• Signs of Overdose: Severe headache, confusion, drowsiness, rapid weight gain, and in extreme cases, seizures or coma.
• Emergency Measures: If an overdose is suspected, the medication must be stopped immediately. Treatment involves strict fluid restriction and, in severe cases, the administration of osmotic diuretics or hypertonic saline in a hospital setting.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as this could lead to a rapid return of symptoms or dangerous changes in blood pressure.

Because vasopressin is a powerful vasoconstrictor, many of its side effects are related to the narrowing of blood vessels. Common experiences include:

• Abdominal Cramping: This occurs as the smooth muscles of the gut contract. It may feel like sharp or dull pains in the stomach area.
• Nausea and Vomiting: Some patients feel a 'queasy' sensation shortly after the medication is administered.
• Skin Blanching (Paleness): The skin may appear very pale or white, especially in the hands and feet, as blood is diverted to the internal organs.
• Headache: Often described as a throbbing sensation, this is common during the initial phases of treatment.
• Dizziness

Vasopressin is a potent medication that requires expert administration. The most critical safety concern is the balance between its life-saving blood pressure effects and the risk of reducing blood flow to vital organs. Because it constricts blood vessels indiscriminately, it can inadvertently 'starve' the heart, intestines, or limbs of oxygen-rich blood. Patients with pre-existing vascular disease must be monitored with extreme vigilance.

No FDA black box warnings for Vasopressin. Despite the absence of a black box warning, the clinical community treats vasopressin as a medication with a narrow therapeutic index, meaning the difference between a helpful dose and a harmful dose is small.

• Cardiovascular Disease: Vasopressin should be used with extreme caution in patients with coronary artery disease, heart failure, or a history of myocardial infarction (heart attack). The drug increases the workload of the heart and can trigger angina or arrhythmias (irregular heartbeats).

While few drugs are strictly contraindicated, the use of Nitrogen Mustard or other highly toxic agents alongside vasopressin is generally avoided due to the risk of severe systemic complications. Additionally, the use of vasopressin in patients with a known allergy to Chlorobutanol (a common preservative) is prohibited.

• Pressor Agents (e.g., Norepinephrine, Epinephrine): When used with other vasopressors, the effect on blood pressure is additive. This can lead to dangerously high blood pressure or severe lack of blood flow to the limbs. While often used together in the ICU, the doses must be adjusted carefully.
• Ganglionic Blocking Agents (e.g., Trimethaphan): These drugs can significantly increase the pressor (blood pressure raising) effect of vasopressin, potentially doubling its impact. This requires an immediate reduction in the vasopressin dose.

There are specific scenarios where Vasopressin must NEVER be used because the risks outweigh any potential benefit:

• Hypersensitivity: If a patient has a known allergy to synthetic vasopressin or chlorobutanol, the drug is strictly contraindicated. An allergic reaction could lead to anaphylaxis, a life-threatening emergency.
• Anuria: In patients who are not producing any urine due to advanced kidney failure (unless being used for blood pressure support in shock), the use of an antidiuretic hormone can lead to rapid and dangerous fluid overload.
• Bilharziasis (Schistosomiasis): In advanced stages of this parasitic infection, vasopressin can cause dangerous changes in the pressure within the portal vein system.

These are conditions where the doctor must carefully weigh the risks versus the benefits:

Vasopressin is classified as Pregnancy Category C (under the older FDA system). This means that animal studies have shown an adverse effect on the fetus, or there are no adequate studies in humans. However, in life-threatening situations like septic shock, the benefit of saving the mother's life often outweighs the potential risk to the fetus. It should be noted that vasopressin can cause uterine contractions similar to oxytocin, which could theoretically lead to premature labor. Its use in pregnancy is strictly reserved for emergencies where no safer alternative is effective.

It is not known whether vasopressin is excreted in human milk. Because many drugs are excreted in milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Given that vasopressin is usually administered in an ICU setting, breastfeeding is typically paused during treatment.

Vasopressin is used in children primarily for central diabetes insipidus. It must be used with extreme caution in infants and very young children because they are at a much higher risk for fluid and electrolyte imbalances. Over-hydration can lead to cerebral edema (brain swelling) very quickly in this population. Safety and effectiveness for vasodilatory shock in pediatric patients have not been as extensively established as in adults, though it is used off-label in pediatric ICUs.

Vasopressin is a nonapeptide (a chain of nine amino acids) that acts as a potent endogenous hormone. Its primary molecular targets are G-protein coupled receptors.

1. 1V1a Receptors: Located on vascular smooth muscle. Activation triggers the Phospholipase C pathway, increasing intracellular calcium, which leads to muscle contraction and vasoconstriction.
2. 2V2 Receptors: Located on the basolateral membrane of the distal tubule and collecting ducts in the kidney. Activation stimulates Adenylate Cyclase, increasing cyclic AMP (cAMP). This triggers the translocation of Aquaporin-2 water channels to the apical membrane, significantly increasing water permeability and reabsorption.